Clinical Trial Update: The SHUNT-V Study for Varices [NA]

View source ↗

Summary

The SHUNT-V study for varices in chronic liver disease has completed, and results were posted on 2025-04-11. The sponsor is HepQuant, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• SHUNT-V

Snippet

Sponsor: HepQuant, LLC | Conditions: Chronic Liver Disease | NA | Status: COMPLETED | Results posted: 2025-04-11